These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33854188)

  • 21. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
    Fu S; Xie L; Li D; Ye P; Luo L
    Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term pronostic value of suPAR in chronic heart failure: reclassification of patients with low MAGGIC score.
    Dupuy AM; Kuster N; Bargnoux AS; Aguilhon S; Huet F; Leclercq F; Pasquié JL; Roubille F; Cristol JP
    Clin Chem Lab Med; 2021 Jun; 59(7):1299-1306. PubMed ID: 33544524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Lee SE; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Park HY; Oh BH
    Korean J Intern Med; 2019 Sep; 34(5):1030-1039. PubMed ID: 30317846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beneficial neurohormonal profiles of beta-blockades in chronic left heart failure].
    Wang F; Xu ZM; Wang L; Bian WY; Jia X; Duan B; Li W; Li YS
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):490-4. PubMed ID: 16080835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
    Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
    J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Heart Rate Reduction with Maximal Tolerable Dose of Bisoprolol on Left Ventricular Reverse Remodeling.
    Choi SW; Han S; Shim WJ; Choi DJ; Kim YJ; Yoo BS; Hwang KK; Jeon HK; Shin MS; Ryu KH
    J Korean Med Sci; 2018 Jun; 33(25):e171. PubMed ID: 29915522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
    Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
    Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.
    Yeh JH; Huang CT; Liu CH; Ruan SY; Tsai YJ; Chien YC; Yang CY; Huang CK; Hsu CL; Kuo LC; Lee PL; Ku SC; Kuo PH; Yu CJ;
    PLoS One; 2014; 9(12):e115301. PubMed ID: 25502236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.
    Düngen HD; Apostolović S; Inkrot S; Tahirović E; Krackhardt F; Pavlović M; Putniković B; Lainscak M; Gelbrich G; Edelmann F; Wachter R; Eschenhagen T; Waagstein F; Follath F; Rauchhaus M; Haverkamp W; Osterziel KJ; Dietz R;
    Clin Res Cardiol; 2008 Sep; 97(9):578-86. PubMed ID: 18542839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
    Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community.
    Whalley GA; Wright SP; Pearl A; Gamble GD; Walsh HJ; Richards M; Doughty RN
    Eur Heart J; 2008 Feb; 29(4):509-16. PubMed ID: 18276620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
    Sanders-van Wijk S; van Asselt AD; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Vuillomenet A; Peter M; Pfisterer ME; Brunner-La Rocca HP;
    JACC Heart Fail; 2013 Feb; 1(1):64-71. PubMed ID: 24621800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Barcelona Bio-Heart Failure risk calculator may predict 1-year mortality in patients with advanced heart failure.
    Szczurek-Wasilewicz W; Skrzypek M; Karmański A; Jurkiewicz M; Gąsior M; Szyguła-Jurkiewicz B
    Pol Arch Intern Med; 2024 Aug; 134(7-8):. PubMed ID: 38804895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value.
    Pastore MC; Mandoli GE; Stefanini A; Ghionzoli N; Carrucola C; De Carli G; Lisi M; Cavigli L; D'Ascenzi F; Focardi M; Valente S; Patti G; Mondillo S; Cameli M
    Int J Cardiol; 2023 Jan; 371():266-272. PubMed ID: 36067924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
    Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
    JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
    Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
    J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.
    Sanders-van Wijk S; Muzzarelli S; Neuhaus M; Kiencke S; Maeder M; Estlinbaum W; Tobler D; Mayer K; Erne P; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Aug; 15(8):910-8. PubMed ID: 23666681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.